AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23302419 — intervention group
Group type: COMPARATOR
Intervention: Diagrammatic goniometry (paper goniometer)
Number of subjects: 24
Study 23302419 — intervention group
Group type: EXPERIMENTAL
Intervention: Both goniometers (standard and paper)
Number of subjects: 24
Study 21808851 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetazidine (20 mg, 3 times/day)
Number of subjects: 60
Study 21808851 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 18296970 — intervention group
Group type: COMPARATOR
Intervention: Heavy Back Squats (HBS)
Number of subjects: 10
Study 15803287 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined mitoxantrone and methylprednisolone therapy
Number of subjects: 65
Study 12242746 — intervention group
Group type: EXPERIMENTAL
Intervention: Male instructors
Number of subjects: 44
Study 12242746 — intervention group
Group type: COMPARATOR
Intervention: Female instructors
Number of subjects: 44
Study 12242746 — intervention group
Group type: EXPERIMENTAL
Intervention: Both male and female instructors
Number of subjects: 44
Study 9824924 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSD checklist (PCL-C)
Number of subjects: 65
Study 7549222 — intervention group
Group type: EXPERIMENTAL
Intervention: Zatebradine (10 mg)
Number of subjects: 16
Study 7549222 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 2686485 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 20
Study 2686485 — intervention group
Group type: COMPARATOR
Intervention: Sodium Nitroprusside (SNP)
Number of subjects: 20
Study 31960497 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fecundity group
Number of subjects: 0
Study 31960497 — intervention group
Group type: COMPARATOR
Intervention: Low-fecundity group
Number of subjects: 0
Study 31960497 — intervention group
Group type: EXPERIMENTAL
Intervention: DEmRNAs SRD5A2, LOC102191297, LOC102171967
Number of subjects: 0
Study 30037019 — intervention group
Group type: EXPERIMENTAL
Intervention: Coconut oil (CoG, n = 18)
Number of subjects: 75
Study 30037019 — intervention group
Group type: EXPERIMENTAL
Intervention: Chia oil (ChG, n = 19)
Number of subjects: 75
Study 30037019 — intervention group
Group type: EXPERIMENTAL
Intervention: Safflower oil (SafG, n = 19)
Number of subjects: 75
Study 30037019 — intervention group
Group type: COMPARATOR
Intervention: Soybean oil placebo (PG, n = 19)
Number of subjects: 75
Study 25641255 — intervention group
Group type: EXPERIMENTAL
Intervention: MBG-0/1
Number of subjects: 3115
Study 25641255 — intervention group
Group type: EXPERIMENTAL
Intervention: MBG-0/1 with normal post-PCI epicardial TIMI-3 flow
Number of subjects: 3115
Study 25641255 — intervention group
Group type: COMPARATOR
Intervention: Normal myocardial perfusion
Number of subjects: 3115
Study 24607500 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based CBT-I workshops
Number of subjects: 151
Study 24607500 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 151
Study 21921071 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (80 mg daily for 6 months)
Number of subjects: 64
Study 21921071 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 20112246 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy‐Adolescent Skills Training (IPT‐AST)
Number of subjects: 57
Study 20112246 — intervention group
Group type: COMPARATOR
Intervention: School Counseling (SC)
Number of subjects: 57
Study 18506741 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-fast chromatographic micro-assay for DPN quantification
Number of subjects: 0
Study 18506741 — intervention group
Group type: EXPERIMENTAL
Intervention: Formulations of DPN
Number of subjects: 0
Study 15816586 — intervention group
Group type: COMPARATOR
Intervention: Postoperative music
Number of subjects: 75
Study 15816586 — intervention group
Group type: COMPARATOR
Intervention: Intraoperative music
Number of subjects: 75
Study 15816586 — intervention group
Group type: EXPERIMENTAL
Intervention: Silence (control group)
Number of subjects: 75
Study 11199956 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion SR
Number of subjects: 15
Study 11199956 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 9714526 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral pamidronate 300 mg daily
Number of subjects: 16
Study 7974586 — intervention group
Group type: EXPERIMENTAL
Intervention: ECST method
Number of subjects: 1001
Study 7974586 — intervention group
Group type: EXPERIMENTAL
Intervention: CC method
Number of subjects: 1001
Study 7974586 — intervention group
Group type: COMPARATOR
Intervention: NASCET method
Number of subjects: 1001
Study 2662982 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic fetal monitoring (EFM) using continuous Doppler and tocodynamometer when membranes intact, and internal fetal scalp electrode and pressure catheter once membranes ruptured.
Number of subjects: 135
Study 2662982 — intervention group
Group type: COMPARATOR
Intervention: Periodic monitoring with a DeLee fetoscope or amplified Doppler.
Number of subjects: 135
Study 2662982 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing support during labor.
Number of subjects: 135
Study 29306223 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative oral carbohydrate intake
Number of subjects: 152
Study 29306223 — intervention group
Group type: COMPARATOR
Intervention: Control group (8-hour preoperative fasting)
Number of subjects: 152
Study 25616519 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein diet (4 g/kg/d)
Number of subjects: 25
Study 25616519 — intervention group
Group type: COMPARATOR
Intervention: Standard-protein diet
Number of subjects: 25
Study 24436758 — intervention group
Group type: EXPERIMENTAL
Intervention: Strut plate
Number of subjects: 13
Study 24436758 — intervention group
Group type: COMPARATOR
Intervention: Champy miniplate
Number of subjects: 13
Study 21851202 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU + DRT + Mentorship for Addictions Problems to Enhance Engagement to Treatment (MAP‐Engage)
Number of subjects: 96
Study 21851202 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU + MAP‐Engage
Number of subjects: 96
Study 21851202 — intervention group
Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 96
Study 19469885 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium carbonate/calcium carbonate (elemental Mg: 86 mg/elemental Ca 100 mg) administered as phosphate binder for 18 months
Number of subjects: 7
Study 19469885 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium carbonate/calcium carbonate (elemental Mg: 86 mg/elemental Ca 100 mg)
Number of subjects: 7
Study 17273633 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of a labor companion during childbirth
Number of subjects: 27
Study 17273633 — intervention group
Group type: EXPERIMENTAL
Intervention: Labor companion's support
Number of subjects: 27
Study 17273633 — intervention group
Group type: EXPERIMENTAL
Intervention: Health care providers' management
Number of subjects: 27
Study 15521232 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (2 mg/kg)
Number of subjects: 100
Study 15521232 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (1 mg/kg)
Number of subjects: 100
Study 15521232 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 100
Study 11679451 — intervention group
Group type: EXPERIMENTAL
Intervention: OGTT + F (75 g glucose + 7.5 g fructose)
Number of subjects: 5
Study 11679451 — intervention group
Group type: COMPARATOR
Intervention: OGTT - F (75 g glucose only)
Number of subjects: 5
Study 9765038 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical spine locking plate (CSLP) in two-level disc fusions
Number of subjects: 18
Study 9765038 — intervention group
Group type: COMPARATOR
Intervention: No plate fixation (grafting without fixation)
Number of subjects: 18
Study 7834919 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate-buffered hemofiltration (lactate concentration 34-44.5 mmol/l)
Number of subjects: 11
Study 7834919 — intervention group
Group type: EXPERIMENTAL
Intervention: Type II bicarbonate-buffered fluid (bicarbonate concentration 39.7 mmol/l)
Number of subjects: 11
Study 7834919 — intervention group
Group type: COMPARATOR
Intervention: Type I bicarbonate-buffered fluid (bicarbonate concentration 31.4 mmol/l)
Number of subjects: 11
Study 7834919 — intervention group
Group type: EXPERIMENTAL
Intervention: Type II bicarbonate fluid (bicarbonate concentration 39.7 mmol/l)
Number of subjects: 11
Study 29544063 — intervention group
Group type: EXPERIMENTAL
Intervention: l-arginine supplementation
Number of subjects: 20
Study 29544063 — intervention group
Group type: COMPARATOR
Intervention: placebo supplementation
Number of subjects: 20
Study 27786346 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity Aerobic Exercise
Number of subjects: 47
Study 27786346 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity Balance/Flexibility
Number of subjects: 47
Study 23804232 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant thrombomodulin
Number of subjects: 0
Study 23804232 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 22951491 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee and hip exercise (KHE) group, n = 28; performed a 4-week program including hip abductors, lateral rotators, and extensors strengthening exercises
Number of subjects: 54
Study 22951491 — intervention group
Group type: COMPARATOR
Intervention: Knee exercise (KE) group, n = 26; performed a 4-week conventional knee-stretching and strengthening program
Number of subjects: 54
Study 20444914 — intervention group
Group type: EXPERIMENTAL
Intervention: Ruboxistaurin mesylate (PKCbeta antagonist)
Number of subjects: 28
Study 20444914 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 19071992 — intervention group
Group type: EXPERIMENTAL
Intervention: Words read aloud with Remember instruction
Number of subjects: 0
Study 19071992 — intervention group
Group type: EXPERIMENTAL
Intervention: Words read aloud with Forget instruction
Number of subjects: 0
Study 19071992 — intervention group
Group type: EXPERIMENTAL
Intervention: Words read silently with Remember instruction
Number of subjects: 0
Study 19071992 — intervention group
Group type: EXPERIMENTAL
Intervention: Words read silently with Forget instruction
Number of subjects: 0
Study 19071992 — intervention group
Group type: EXPERIMENTAL
Intervention: All studied items (implicit speeded reading test)
Number of subjects: 0
Study 16708408 — intervention group
Group type: EXPERIMENTAL
Intervention: Plantago ovata (2 sachets daily of 3.26 g for 20 days)
Number of subjects: 98
Study 16708408 — intervention group
Group type: COMPARATOR
Intervention: Glycerin oil (control group)
Number of subjects: 98
Study 12615633 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment maneuvers during suctioning
Number of subjects: 9
Study 12615633 — intervention group
Group type: COMPARATOR
Intervention: Disconnection from the ventilator
Number of subjects: 9
Study 12615633 — intervention group
Group type: COMPARATOR
Intervention: Suctioning through the swivel adapter
Number of subjects: 9
Study 12615633 — intervention group
Group type: COMPARATOR
Intervention: Suctioning with a closed system
Number of subjects: 9
Study 12615633 — intervention group
Group type: COMPARATOR
Intervention: Suctioning with pressure-supported breaths
Number of subjects: 9
Study 12615633 — intervention group
Group type: COMPARATOR
Intervention: Recruitment after disconnection
Number of subjects: 9
Study 12615633 — intervention group
Group type: COMPARATOR
Intervention: Recruitment using the swivel adapter
Number of subjects: 9
Study 12615633 — intervention group
Group type: COMPARATOR
Intervention: Recruitment with the closed system
Number of subjects: 9
Study 10781391 — intervention group
Group type: COMPARATOR
Intervention: Sodium selenite (50 microg of Se daily for 28 days)
Number of subjects: 45
Study 10781391 — intervention group
Group type: COMPARATOR
Intervention: Selenomethionine (50 microg of Se daily for 28 days)
Number of subjects: 45
Study 10781391 — intervention group
Group type: COMPARATOR
Intervention: Both treatments (Sodium selenite and Selenomethionine)
Number of subjects: 45
Study 8748408 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextran 40-based preservation solution (Dex-PS)
Number of subjects: 174
Study 8748408 — intervention group
Group type: COMPARATOR
Intervention: University of Wisconsin (UW) solution
Number of subjects: 174
Study 1407917 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg intravaginal PGE2 tablets
Number of subjects: 18
Study 1407917 — intervention group
Group type: COMPARATOR
Intervention: Placebo intravaginal tablets (Control)
Number of subjects: 18
Study 2996161 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin and Sulbactam
Number of subjects: 0
Study 2996161 — intervention group
Group type: COMPARATOR
Intervention: Clindamycin and Gentamicin
Number of subjects: 0
Study 2996161 — intervention group
Group type: EXPERIMENTAL
Intervention: Both combinations of antibiotics
Number of subjects: 0
Study 2996161 — intervention group
Group type: EXPERIMENTAL
Intervention: Pseudomonas isolated patients
Number of subjects: 0
Study 31688579 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (0.1 mg/d) + 200 mg progesterone (12 d every 3 mo)
Number of subjects: 172
Study 31688579 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 172
Study 30571235 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive antihypertensive treatment (target systolic blood pressure <120 mm Hg)
Number of subjects: 4733
Study 30571235 — intervention group
Group type: COMPARATOR
Intervention: Standard antihypertensive treatment (target systolic blood pressure <140 mm Hg)
Number of subjects: 4733
Study 30571235 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups (intensive and standard)
Number of subjects: 4733
Study 26707957 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric exercise program (4 sessions per week for 4 weeks)
Number of subjects: 29
Study 26707957 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic exercise program (4 sessions per week for 4 weeks)
Number of subjects: 29
Study 26707957 — intervention group
Group type: COMPARATOR
Intervention: Isometric exercise program
Number of subjects: 29
Study 26707957 — intervention group
Group type: COMPARATOR
Intervention: Isotonic exercise program
Number of subjects: 29
Study 24368552 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (3,000 mg × day(‐1) for 3 weeks)
Number of subjects: 17
Study 24368552 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 22747575 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor alone
Number of subjects: 58
Study 22747575 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor with enoxaparin
Number of subjects: 58
Study 22747575 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor with UFH
Number of subjects: 58
Study 20149950 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency Management (CM) sessions
Number of subjects: 1613
Study 20149950 — intervention group
Group type: EXPERIMENTAL
Intervention: General items subscale of CMCS
Number of subjects: 1613
Study 20149950 — intervention group
Group type: EXPERIMENTAL
Intervention: CMCS scores during training phase
Number of subjects: 1613
Study 17378784 — intervention group
Group type: EXPERIMENTAL
Intervention: Venous occlusion during injection of propofol (10 mg/ml, 0.5 ml over 30 s)
Number of subjects: 75
Study 17378784 — intervention group
Group type: COMPARATOR
Intervention: No venous occlusion during injection of propofol (10 mg/ml, 0.5 ml over 30 s)
Number of subjects: 75
Study 16322410 — intervention group
Group type: EXPERIMENTAL
Intervention: Template-driven medical documentation system (T-System for Primary Care)
Number of subjects: 1339
Study 16322410 — intervention group
Group type: COMPARATOR
Intervention: Undirected handwritten documentation
Number of subjects: 1339
Study 11981680 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic nasal continuous positive airway pressure (nCPAP) for the first postoperative night
Number of subjects: 204
Study 11981680 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 204
Study 9860107 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide 450 mg b.i.d.
Number of subjects: 12
Study 9860107 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide 600 mg b.i.d.
Number of subjects: 12
Study 9860107 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide (both doses)
Number of subjects: 12
Study 9860107 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 7614813 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose (75 g)
Number of subjects: 14
Study 7614813 — intervention group
Group type: COMPARATOR
Intervention: Tap water
Number of subjects: 14
Study 2173443 — intervention group
Group type: EXPERIMENTAL
Intervention: 2‐chloroprocaine
Number of subjects: 60
Study 2173443 — intervention group
Group type: EXPERIMENTAL
Intervention: lidocaine
Number of subjects: 60
Study 2173443 — intervention group
Group type: EXPERIMENTAL
Intervention: butorphanol 2 mg
Number of subjects: 60
Study 2173443 — intervention group
Group type: EXPERIMENTAL
Intervention: fentanyl 50 micrograms
Number of subjects: 60
Study 2173443 — intervention group
Group type: COMPARATOR
Intervention: butorphanol
Number of subjects: 60
Study 2173443 — intervention group
Group type: COMPARATOR
Intervention: fentanyl
Number of subjects: 60
Study 26099 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipotassium chlorazepate 20 mg at bedtime
Number of subjects: 12
Study 26099 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipotassium chlorazepate divided daily dose (5 + 5 + 10 mg)
Number of subjects: 12
Study 26099 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31638282 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 28
Study 31638282 — intervention group
Group type: COMPARATOR
Intervention: Ipilimumab
Number of subjects: 28
Study 28316280 — intervention group
Group type: EXPERIMENTAL
Intervention: PLAB part 1 scores
Number of subjects: 27330
Study 28316280 — intervention group
Group type: EXPERIMENTAL
Intervention: PLAB part 2 scores
Number of subjects: 27330
Study 28316280 — intervention group
Group type: EXPERIMENTAL
Intervention: IELTS reading scores
Number of subjects: 27330
Study 28316280 — intervention group
Group type: EXPERIMENTAL
Intervention: IELTS listening scores
Number of subjects: 27330
Study 28316280 — intervention group
Group type: EXPERIMENTAL
Intervention: IELTS speaking scores
Number of subjects: 27330
Study 28316280 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple resits at either part of the PLAB
Number of subjects: 27330
Study 26188167 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum (6mg)
Number of subjects: 44
Study 26188167 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 26188167 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis users
Number of subjects: 44
Study 26188167 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy long-term users (HLT)
Number of subjects: 44
Study 26188167 — intervention group
Group type: EXPERIMENTAL
Intervention: Light short-term users (LST)
Number of subjects: 44
Study 23365149 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous zoledronic acid (ZOL) 5 mg once yearly
Number of subjects: 793
Study 23365149 — intervention group
Group type: COMPARATOR
Intervention: Oral risedronate (RIS)
Number of subjects: 793
Study 21078841 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg synthetic oral THC
Number of subjects: 9
Study 21078841 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg synthetic oral THC
Number of subjects: 9
Study 21078841 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose Sativex (5.4 mg THC and 5.0 mg CBD)
Number of subjects: 9
Study 21078841 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose Sativex (16.2 mg THC and 15.0 mg CBD)
Number of subjects: 9
Study 21078841 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 21078841 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg oral THC
Number of subjects: 9
Study 21078841 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg oral THC
Number of subjects: 9
Study 19608695 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of rotigotine (1.2 mg over 12 hours)
Number of subjects: 6
Study 19608695 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal application of rotigotine (4.5 mg via 10-cm² patch for 24 hours)
Number of subjects: 6
Study 16721463 — intervention group
Group type: EXPERIMENTAL
Intervention: One‐Step (Bisco)
Number of subjects: 50
Study 16721463 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluma One Bond (Heraeus Kulzer)
Number of subjects: 50
Study 16721463 — intervention group
Group type: EXPERIMENTAL
Intervention: Solobond M (Voco)
Number of subjects: 50
Study 16721463 — intervention group
Group type: EXPERIMENTAL
Intervention: TenureQuik w/F (Den‐Mat)
Number of subjects: 50
Study 16721463 — intervention group
Group type: COMPARATOR
Intervention: OptiBond Solo Plus (Kerr)
Number of subjects: 50
Study 14677616 — intervention group
Group type: EXPERIMENTAL
Intervention: One Step adhesive with A2 Heliomolar RO liner
Number of subjects: 80
Study 14677616 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime & Bond NT adhesive with A2 Heliomolar Flow liner
Number of subjects: 80
Study 14677616 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime & Bond NT adhesive with A2 Bisfil 2B liner
Number of subjects: 80
Study 14677616 — intervention group
Group type: COMPARATOR
Intervention: No liner used (D and H subgroups)
Number of subjects: 80
Study 14677616 — intervention group
Group type: COMPARATOR
Intervention: Prime & Bond NT adhesive
Number of subjects: 80
Study 11099054 — intervention group
Group type: EXPERIMENTAL
Intervention: Eradication therapy (metronidazole, amoxicillin, and omeprazole for 2 weeks) followed by placebo for 1 year
Number of subjects: 276
Study 11099054 — intervention group
Group type: COMPARATOR
Intervention: Long-term omeprazole treatment (20 mg twice daily until healing, followed by 20 mg/day for 1 year)
Number of subjects: 276
Study 11099054 — intervention group
Group type: EXPERIMENTAL
Intervention: Eradication therapy
Number of subjects: 276
Study 11099054 — intervention group
Group type: COMPARATOR
Intervention: Long-term omeprazole
Number of subjects: 276
Study 11099054 — intervention group
Group type: EXPERIMENTAL
Intervention: Eradication therapy and long-term omeprazole
Number of subjects: 276